Honokiol targets mitochondria to halt cancer progression and metastasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Honokiol targets mitochondria to halt cancer progression and metastasis
Authors
Keywords
-
Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 60, Issue 6, Pages 1383-1395
Publisher
Wiley
Online
2016-04-11
DOI
10.1002/mnfr.201501007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation
- (2015) Ying Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lung Cancer Brain Metastases
- (2015) Sarah B. Goldberg et al. CANCER JOURNAL
- Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism
- (2015) Gang Cheng et al. CANCER LETTERS
- STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
- (2015) Heng Yang et al. CANCER RESEARCH
- The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats
- (2015) Wang Jun-jun et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3
- (2015) Daniel J. Garama et al. MOLECULAR AND CELLULAR BIOLOGY
- Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition
- (2015) Shing-Hwa Liu et al. Molecular Oncology
- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation
- (2015) Linna Li et al. PHARMACOLOGY & THERAPEUTICS
- Acute and sub-chronic toxicity studies of honokiol microemulsion
- (2015) Qianqian Zhang et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Honokiol Downregulates Kruppel-Like Factor 4 Expression, Attenuates Inflammation, and Reduces Histopathology After Spinal Cord Injury in Rats
- (2015) Jia Liu et al. SPINE
- Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
- (2015) Vinodkumar B. Pillai et al. Nature Communications
- Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
- (2015) Tripti Singh et al. Oncotarget
- SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway
- (2015) Yizhou Quan et al. Oncotarget
- Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
- (2015) Dimiter B. Avtanski et al. Oncotarget
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers
- (2015) James B. Stewart et al. PLoS Genetics
- Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells
- (2015) I-Chun Lai et al. PLoS One
- Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
- (2014) G Cheng et al. BRITISH JOURNAL OF CANCER
- Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function
- (2014) J. Pan et al. Cancer Prevention Research
- Honokiol nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system
- (2014) Meihua Han et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and 13C stable isotope labeling
- (2014) Yinfeng Dong et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- UPLC-MS/MS-ESI assay for simultaneous determination of magnolol and honokiol in rat plasma: Application to pharmacokinetic study after administration emulsion of the isomer
- (2014) Yi-Ling Sheng et al. JOURNAL OF ETHNOPHARMACOLOGY
- Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
- (2014) So Hyun Bae et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Honokiol inhibits melanoma stem cells by targeting notch signaling
- (2014) Gaurav Kaushik et al. MOLECULAR CARCINOGENESIS
- Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis
- (2014) Dimiter B. Avtanski et al. Molecular Oncology
- Honokiol Suppresses Renal Cancer Cells’ Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling
- (2014) Weidong Li et al. MOLECULES AND CELLS
- SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1
- (2014) S M Jeong et al. ONCOGENE
- Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis
- (2014) Xu Wang et al. PLoS One
- Honokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats
- (2014) Chuan-Chih Hsu et al. International Journal of Endocrinology
- Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells
- (2013) H. Hua et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death
- (2013) Gang Cheng et al. BMC CANCER
- Chemoprevention of Lung Squamous Cell Carcinoma by Ginseng
- (2013) J. Pan et al. Cancer Prevention Research
- Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
- (2013) Hung-Chuan Pan et al. CARCINOGENESIS
- Identification of metabolites of honokiol in rat urine using 13C stable isotope labeling and liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry
- (2013) Juan Liu et al. JOURNAL OF CHROMATOGRAPHY A
- Identification of honokiol metabolites in rats by the method of stable isotope cluster technique and ultra-high performance liquid chromatography/quadrupole-time-of-flight mass spectrometry
- (2013) Huijun Lai et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma
- (2013) Xiaoyin Jiang et al. JOURNAL OF NEURO-ONCOLOGY
- Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
- (2013) Young-Je Kim et al. MOLECULAR NUTRITION & FOOD RESEARCH
- EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors
- (2013) J Wu et al. ONCOGENE
- Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling
- (2013) Tripti Singh et al. PLoS One
- Honokiol and magnolol stimulate glucose uptake by activating PI3K-dependent Akt in L6 myotubes
- (2012) Sun-Sil Choi et al. BIOFACTORS
- Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
- (2012) G. Cheng et al. CANCER RESEARCH
- Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
- (2012) M. Sen et al. CLINICAL CANCER RESEARCH
- Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
- (2012) S. Arora et al. CURRENT MOLECULAR MEDICINE
- Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo
- (2012) Tripti Singh et al. Epigenetics
- The Import of the Transcription Factor STAT3 into Mitochondria Depends on GRIM-19, a Component of the Electron Transport Chain
- (2012) Prasad Tammineni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adipokine leptin in obesity-related pathology of breast cancer
- (2012) Amitabha Ray JOURNAL OF BIOSCIENCES
- Mitochondrial Respiration - An Important Therapeutic Target in Melanoma
- (2012) Michelle Barbi de Moura et al. PLoS One
- Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects
- (2011) Zhiyun He et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- O6-Methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma
- (2011) Reiko Watanabe et al. Brain Tumor Pathology
- Antimetastatic activity of honokiol in osteosarcoma
- (2011) Patrick Steinmann et al. CANCER
- Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
- (2011) James W. Antoon et al. CANCER BIOLOGY & THERAPY
- STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
- (2011) L. Lin et al. CANCER RESEARCH
- Differences underlying EGFR and HER2 oncogene addiction
- (2011) Anthony C. Faber et al. CELL CYCLE
- Curcumin
- (2011) Mark G. Alexandrow et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
- (2011) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- In vitro metabolism and disposition of honokiol in rat and human livers
- (2011) Michaela Böhmdorfer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Overcoming Erlotinib Resistance in EGFR Mutation-Positive Non-Small Cell Lung Cancer Cells by Targeting Survivin
- (2011) K. Okamoto et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondrial Localized STAT3 Is Involved in NGF Induced Neurite Outgrowth
- (2011) Lihan Zhou et al. PLoS One
- Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells
- (2011) Sumit Arora et al. PLoS One
- Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model
- (2011) Xianhuo Wang et al. PLoS One
- Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
- (2010) R. J. Leeman-Neill et al. CLINICAL CANCER RESEARCH
- PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
- (2010) Marco Falasca CURRENT PHARMACEUTICAL DESIGN
- Akt associates with nuclear factor κB and plays an important role in chemoresistance of gastric cancer cells
- (2010) Yu ONCOLOGY REPORTS
- Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells
- (2010) Chu Peng Hoi et al. PHYTOTHERAPY RESEARCH
- Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes
- (2010) Claudia Miranda et al. PLoS One
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression
- (2009) Byung Hun Kim et al. ACTA PHARMACOLOGICA SINICA
- Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
- (2009) Levi E. Fried et al. ANTIOXIDANTS & REDOX SIGNALING
- Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells
- (2009) Eun-Jung Park et al. CANCER LETTERS
- Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity
- (2009) Jia Hu et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model
- (2008) Qi-qi Jiang et al. BMC CANCER
- The EGFR-STAT3 Oncogenic Pathway Up-regulates the Eme1 Endonuclease to Reduce DNA Damage after Topoisomerase I Inhibition
- (2008) A. Vigneron et al. CANCER RESEARCH
- Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer
- (2008) Hongyu Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model
- (2008) Jing Wen et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models
- (2008) Wenli Hou et al. PHYTOTHERAPY RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now